CRISPR Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceGlobeNewsWire • 01/03/24
AI and Automation Leaders for 2024: 7 Stocks to Stay Ahead of the Robot UprisingInvestorPlace • 12/30/23
Up More Than 60% in 2023, Is It Too Late to Buy This Soaring Biotech Stock?The Motley Fool • 12/22/23
6 Words That Explain Why CRISPR Stock Isn't Soaring Despite the Recent FDA Approval for Its Gene-Editing TherapyThe Motley Fool • 12/21/23
Here's the 1 Key Reason You Might Want to Buy CRISPR Therapeutics Stock on the DipThe Motley Fool • 12/16/23